Sprout Pharmaceuticals' Acquisition - II

Sprout Pharmaceuticals raised a round of funding on November 06, 2017.

Sprout Pharmaceuticals is focused on the commercialization of products that address unmet medical needs in the field of female sexual health. Sprout Pharmaceuticals has acquired flibanserin, a central…

Articles about Sprout Pharmaceuticals' Acquisition - II: